While each of the monotherapies moderately increased, combination of 1 μM imatinib and two- to low three-digit nanomolar concentrations of S63845 markedly enhanced further the rate of caspase-3/7 positive CML stem/progenitor cells in both samples. The gene discussed is CASP3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.